Make 2019 the year you and your team get the most from Bp Premier, with these fabulous training courses in a capital city near you. Whether you want to know about Management Essentials, Clinical Essentials, Advanced Management, or the new Bp Comms features coming out in Bp Premier Indigo SPI – there’s a course for you. Check the dates and locations here
Our Support Team will be here for you over the Christmas/New Year period: WORK DAYS (27th, 28th and 31st December) AUSTRALIA Bp Premier: 7am to 6pm (AEST) Bp VIP.net: 8am to 6pm (AEDT) Bp Allied: 8am to 5pm (AEDT) NEW ZEALAND Bp VIP.net and VIP Gold: 7am to 6pm (NZDT) PUBLIC HOLIDAYS AUS: 25th & 26th December, 1st January NZ: 25th & 26th December, 1st & 2nd January Available for Emergency Calls: Australia: 1300 40 1111 New Zealand: 0800 40 1111 Our Sales Team will be here for you on workdays from 8am to 5pm between Christmas and New Year (27th, 28th and 31st December) Email: email@example.com Australia: 1300 40 1111 (AEST) New Zealand: 0800 40 1111
Best Practice has completed the development of a direct load reporting tool for nKPI, HCP, and certain OSR data for our Aboriginal Community Controlled Health Services. The new Bp Premier Reporting Tool is currently being tested by a number of our beta sites and will be available for the December 2018 reporting period. All sites will be emailed instructions on installing and using the tool prior to the reporting date for the December 2018 reporting period. The benefits of this tool include:
- Reduce the time your staff spend on producing reports for your practice.
- Send reports directly to the Federal Department of Health’s Health Data Portal.
- Preview summary and detailed data before submitting the report through the easy-to-use wizard interface.
Best Practice Software has developed a survey to gauge industry and customer opinion about the recent exclusive arrangement issue surrounding the RACGP and Canadian software developer of Hello Health. Best Practice CEO Dr Frank Pyefinch said it was important to find out what the medical community really thinks. “The RACGP has stated that ”relevant and convenient software that is suitable for the general practice environment and the unique and evolving needs of Australian GPs … is something RACGP members have been asking for”. Dr Pyefinch said. “We would like to know if respondents agree with that statement and whether they think that software could be sourced in Australia”. “We are also interested to know whether respondents think the RACGP should have an exclusive commercial partnership with one vendor. The findings of the Survey will form the basis of our communications with the RACGP as we believe our voices should be heard – not only as RACGP members, but also as Australian software providers who have supported the RACGP over many years”. The survey is open to all and can be accessed here.
For the medical community, the annual R U OK? Day reminds us to stay connected, have meaningful conversations and encourage more people to ask R U OK? at work, school and in the community. The website includes suggestions for simple steps that could save a life :
- Encourage action
- Check in
- Lifeline, 1311 14 for 24/7 crisis support, the Suicide Call Back at 1300 659 467
- kidshelpline at 1800 55 1800 for counselling to young people under 25 years
- Griefline on 1300 845 745
Getting Health Screening Advice from your trusted health professional Recently, a TV show gave the impression that having a blood test for prostate specific antigen (PSA) and digital rectal examination by a Urologist for prostate cancer was potentially life-saving, and showed a popular presenter having the screening tests done. The specific benefits and harms were not broken down, nor quantified. There was no discussion about the very well documented pros and cons to weigh up before the test and although acknowledging the risk of impotency and incontinence as a consequence of prostate surgery, it was framed as though it was a thing of the past, “The treatments are so vast these days that it’s not as bad as all that, and you’ve got to get checked. You must get checked.” For men aged 50-69 (without a family history of prostate cancer) the benefit/harm debate for prostate screening using the PSA test is unclear and open to individual interpretation. The decision to have the screening test is a personal one and needs to be done after weighing up the benefits, harms and uncertainties of prostate cancer screening. If you have a PSA test, you are much more likely to be over-diagnosed and over-treated for prostate cancer than have your life saved from early detection of a nasty form of the disease. This is why the Australian Government does not have a funded, organised prostate screening program and why the Royal Australian College of General Practitioners advises members not to recommend PSA screening to patients. A digital rectal examination is no longer recommended should a man request screening for prostate cancer after being informed about the risks and benefits of testing. The National Health and Medical Research Council (NHMRC) advises that a patient who asks a GP about the tests, should be informed of the following information calculated for men in their 60s with no first-degree relatives affected by prostate cancer who have yearly PSA tests. The stated potential benefits are reassurance if the PSA is normal or very low, early detection and early treatment, hopefully cure. The potential harms are false positive results, with unnecessary biopsy required, false negatives, over-diagnosis and overtreatment resulting in harmful effects without any health benefit. Potential Benefits:
- For every 1000 men tested, 2 men will avoid death from prostate cancer before they reach 85 years. This benefit seems greater for men with a strong family history of the disease
- For every 1000 men tested, 2 men will avoid metastatic prostate cancer before the age of 85 years
- For every 1000 men tested, 28 men will have prostate cancer diagnosed, many of whom would have remained without symptoms for life
- For every 1000 men treated, 25 men will have surgery or radiation because of uncertainty about which cancers need to be treated. Many would do well without treatment
- 7 to 10 of these 25 men will develop persistent impotence and/or incontinence and some will develop persisting bowel problems from the treatment
- For every 2000 men tested, one man will have a serious cardiovascular event, such as a heart attack because of the treatment